MediMint is a blockchain-based platform that aims to tokenize high-value diagnostic medical equipment, such as MRI, CT, and ultrasound machines. The project seeks to create a scalable model for deploying and managing healthcare infrastructure by representing revenue shares from these machines as on-chain digital assets. [1] [2]
MediMint is a real-world asset (RWA) tokenization project designed to address challenges in healthcare infrastructure financing and management, with an initial focus on markets in India and Africa. [3] The platform's core function is to transform expensive medical equipment into digital assets, which allows for fractional ownership and the distribution of revenue generated from their use. The model is intended to provide hospitals and diagnostic centers with an alternative financing mechanism to acquire or upgrade advanced machinery without prohibitive upfront costs. [3]
The project's stated vision is to integrate advanced medical equipment into global healthcare ecosystems, bridging the gap between technological innovation and healthcare accessibility. Every diagnostic scan and subsequent revenue split is intended to be tracked on-chain, creating an immutable ledger for verifying returns and machine usage. The project is reportedly backed by a network of over 300 hospitals and focuses on generating real-world yield from tangible medical services. [1] [4]
- Blockchain Integration: The platform is built on blockchain technology to ensure that operational and financial transactions are recorded in a secure, transparent, and traceable manner. [1]
- Revenue Tokenization: It tokenizes the revenue generated by diagnostic machines, enabling the tracking and distribution of earnings among token holders. [1]
- Smart Contract Execution: The system is intended to use pre-programmed smart contracts to automatically calculate and execute yield distribution to token holders based on recorded revenue from medical scans. [1]
- Real-Time Data Logging: Every transaction, including patient scans and machine operations, is designed to be logged in real-time on-chain to reduce data discrepancies and promote accountability. [2]
- Yield Authentication: The platform employs a data tracking mechanism to authenticate the yield generated by each tokenized machine, aiming to ensure that revenue from patient scans is traceable and verifiable. [2]
- Machine Connectivity: A focus of the platform is creating seamless connectivity between radiology machines and associated laboratory software. This integration is crucial for the automated flow of data from the diagnostic scan to the final token-based revenue tracking. [2]
- Analytics Dashboard: A user-facing dashboard is a planned feature that would allow stakeholders to view key metrics, including their token holdings and total earnings to date. [1]
The MediMint ecosystem is structured to connect various stakeholders within the healthcare and investment sectors. The primary participants include:
- Healthcare Providers: Hospitals and diagnostic centers that operate the medical equipment. The project states its network includes over 300 hospitals across India and Africa. [1]
- Investors (Token Holders): Individuals and entities who purchase MediMint's RWA tokens, providing capital to fund the medical equipment and in turn receiving a share of the revenue generated. [3]
- Patients: The end-users of the diagnostic services whose scans generate the revenue that sustains the ecosystem. [3]
- The MediMint Platform: The core technology infrastructure that facilitates the tokenization, on-chain data tracking, and automated revenue distribution via smart contracts. [1]
- Democratizing investment in high-value medical infrastructure by allowing for fractional ownership. [1]
- Providing a transparent and automated revenue-sharing model for healthcare equipment owners and operators. [1]
- Enhancing the operational and financial efficiency of hospitals and diagnostic centers. [1]
- Facilitating the deployment of advanced medical technology in underserved communities by offering an alternative financing model. [3]
- Creating a mechanism for investors to generate yield from real-world, non-volatile assets in the healthcare sector. [4]
- Establishing a verifiable on-chain record of patient scans and revenue for auditing and accountability purposes. [2]
- 2025 (Q1–Q4): Blockchain Development and Token Launch Development of the core blockchain infrastructure alongside the pre-sale process and token generation event, establishing the MDMT token within the ecosystem.
- 2026: AI and Data Marketplace Introduction Expansion of token utility to support healthcare data exchange and AI-driven analytics through a dedicated marketplace.
- 2027: Global Expansion and DAO Governance Scaling of the ecosystem to multiple international markets, with the introduction of decentralized governance mechanisms.
- 2028: Token Renewal and Deflationary Measures Initiation of system renewal cycles and implementation of supply-reduction mechanisms intended to support long-term sustainability. [8]
MediMint utilizes the Medimint Token ($MDMT), an ERC-20 asset issued on the Ethereum blockchain, which functions as both a utility and governance token within the protocol. MDMT has a fixed total supply of 1,000,000,000 tokens with 18 decimals. Approximately 350,000,000 tokens (35% of total supply) are expected to be in circulation, with the remaining 650,000,000 tokens subject to vesting schedules. [5]
- Represents a fractionalized share or direct ownership stake in a revenue-generating diagnostic machine. [3] [4]
- Entitles the holder to receive a proportional share of the yield derived from the real-world use of the tokenized medical equipment. [1] [6]
- Public Sale (35%): 350,000,000 MDMT allocated to public participants, with 10% unlocked at the token generation event and the remainder released through quarterly vesting over an 18-month period.
- Team and Advisors (15%): 150,000,000 MDMT subject to a 24-month lockup, followed by linear vesting over 48 months.
- Reserve Fund (20%): 200,000,000 MDMT held in reserve, locked and released based on predefined milestones related to research, development, and system integration.
- Liquidity and Market Making (10%): 100,000,000 MDMT allocated for liquidity support, with gradual distribution after listing to manage market conditions.
- Marketing and Partnerships (10%): 100,000,000 MDMT released linearly over 12 months, contingent on verified partnership and outreach activities.
- Community and Staking Incentives (10%): 100,000,000 MDMT distributed over an extended period of up to five years to support staking participation, governance involvement, and referral programs. [7]
- Avisa Group: The project's CEO, Vikash Sharma, is also the Group CEO of Avisa Group, which is described as running a chain of over 350 hospitals. This relationship forms the basis for MediMint's access to a network of healthcare facilities. [1]
- Avisa Smart: The technical architecture of the MediMint platform is built in partnership with or using technology from Avisa Smart. [3]
- Hospital Network: The project states it is backed by a network of over 300 hospitals located across India and Africa, which serve as the operators of the tokenized equipment. [1] [4]